Description-The percentage of women 67–85 years of age who suffered a fracture and who had either a bone mineral density (BMD) test or prescription for a drug to treat osteoporosis in the six months after the fracture.


References- OMW


Denominator-The eligible population.  67–85 years as of December 31 of the measurement year.


Denominator Exclusions or Exceptions (when applicable)-(Bone Mineral Density Tests Value Set)(Osteoporosis Medications Value Set)


Numerator-

         -A BMD test (Bone Mineral Density Tests Value Set), in any setting, on the IESD or in the 180-day (6-month) period after the IESD.

         -If the IESD was an inpatient stay, a BMD test (Bone Mineral Density Tests Value Set) during the inpatient stay.

         -Osteoporosis therapy (Osteoporosis Medications Value Set) on the IESD or in the 180-day (6-month) period after the IESD.

         -If the IESD was an inpatient stay, long-acting osteoporosis therapy (Long-Acting Osteoporosis Medications Value Set) during the inpatient stay.

         -A dispensed prescription to treat osteoporosis (Table OMW-C) on the IESD or in the 180-day (6-month) period after the IESD.